Strategies for management of stable coronary disease in type 2 diabetes mellitus

Jeremy P. Berman, Sanjum S. Sethi, Michael E. Farkouh

Research output: Contribution to journalArticlepeer-review


In recent decades, there have been significant advances in both surgical and minimally invasive approaches to revascularization in ischemic heart disease. This article discusses the evidence from key clinical trials comparing the various management strategies in stable coronary artery disease, and culminates in a discussion of the recently published Future Revascularization Evaluation in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM) trial, which randomized patients with type 2 diabetes mellitus and multivessel coronary disease to coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) with drug-eluting stents, and found, for the first time, a survival advantage with CABG relative to PCI.

Original languageEnglish (US)
Pages (from-to)S50-S58
JournalReviews in Cardiovascular Medicine
Issue numberSUPPL.
StatePublished - 2013


  • Coronary artery disease
  • Drug-eluting stents
  • Type 2 diabetes mellitus


Dive into the research topics of 'Strategies for management of stable coronary disease in type 2 diabetes mellitus'. Together they form a unique fingerprint.

Cite this